Patents by Inventor Ashokkumar Shenvi

Ashokkumar Shenvi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090170851
    Abstract: Compounds according to Formula (I): wherein R1, R2, R3, and R4 are as defined in the specification, pharmaceutically-acceptable salts, methods of making, pharmaceutical compositions containing and methods for using the same.
    Type: Application
    Filed: March 13, 2009
    Publication date: July 2, 2009
    Inventors: Peter Bernstein, Daniel Hill, David Nugiel, Edward Pierson, Ashokkumar Shenvi, Robert Jacobs
  • Publication number: 20080076752
    Abstract: Compounds having the formula (I) pharmaceutical compositions containing them and their methods of use for the treatment of neurological disorders related to amyloid ? protein production and neurological disorders such as Alzheimer's disease. These compounds inhibit ? secretase and thereby inhibit the production of amyloid ? protein, thereby acting to prevent the formation of neurological deposits of amyloid protein.
    Type: Application
    Filed: August 24, 2007
    Publication date: March 27, 2008
    Applicant: ASTRAZENECA AB
    Inventors: Christopher Becker, Bruce Dembofsky, Robert Jacobs, James Kang, Cyrus Ohnmacht, James Rosamond, Ashokkumar Shenvi, Thomas Simpson, James Woods
  • Publication number: 20070185107
    Abstract: Compounds according to Formula (I): wherein R1, R2, R3, and R4 are as defined in the specification, pharmaceutically-acceptable salts, methods of making, pharmaceutical compositions containing and methods for using the same.
    Type: Application
    Filed: November 3, 2006
    Publication date: August 9, 2007
    Applicant: AstraZeneca AB
    Inventors: Peter Bernstein, Daniel Hill, David Nugiel, Edward Pierson, Ashokkumar Shenvi, Robert Jacobs
  • Publication number: 20070021406
    Abstract: The present application relates to internally cyclized naphthamide compounds of the formula Ia (wherein R1a, R1b, R1c, R2, R3, R4, R5, R6, R7, R8, X1, X2, Y, Z, and n are as defined herein), which are useful, for example, for antagonizing the pharmacological actions of the neurokinin 1 (NK1) receptor.
    Type: Application
    Filed: January 24, 2005
    Publication date: January 25, 2007
    Inventors: Jeffrey Albert, Peter Bernstein, Cyrus Ohnmacht, Keith Russell, Ashokkumar Shenvi
  • Publication number: 20070010526
    Abstract: Provided herein is a compound of the formula (I), wherein said compounds are useful for the treatment of psychiatric disorders including but not limited to depression, generalized anxiety, eating disorders, dementia, panic disorder, and sleep disorders. The compounds may also be useful in the treatment of gastrointestinal disorders, cardiovascular regulation, motor disorders, endocrine disorders, vasospasm and sexual dysfunction. The compounds are 5HT1B and 5HT1D antagonists.
    Type: Application
    Filed: November 1, 2002
    Publication date: January 11, 2007
    Inventors: Markus Haeberlein, Christof Angst, Daniel Hill, Robert Jacobs, Gary Moore, Edward Pierson, Ashokkumar Shenvi
  • Publication number: 20060089346
    Abstract: Compounds having the formula (1) pharmaceutical compositions containing them and their methods of use for the treatment of neurological disorders related to amyloid B protein production and neurological disorders such as Alzheimer's disease. These compounds inhibit ? secretase and thereby inhibit the production of amyloid ? protein, thereby acting to prevent the formation of neurological deposits of amyloid protein.
    Type: Application
    Filed: October 2, 2003
    Publication date: April 27, 2006
    Applicant: AstraZeneca AB
    Inventors: Christopher Becker, Bruce Dembofsky, Robert Jacobs, James Kang, Cyrus Ohnmacht, James Rosamond, Ashokkumar Shenvi, Thomas Simpson, James Woods